BTAFF
British American Tobacco p.l.c.
$62.75
+2.72%
No data for this timeframe.
Vol
SEC Reports17
Recent Activity
Jun 8, 2026
SEC
British American Tobacco filed a Form 6-K on June 8, 2026, disclosing a routine insider share purchase by Yulia Wheaton,
6-K — Impact 1/10
Jun 5, 2026
SEC
CEO Tadeu Marroco and his PCA Luciana Franco Do Amaral purchased 5,000 ordinary shares at £43.06 each (total £215,300) o
6-K — Impact 2/10
Jun 4, 2026
SEC
British American Tobacco filed a Form 6-K disclosing routine share purchases by the CEO and other PDMRs under the HMRC-a
6-K — Impact 1/10
Analyst Ratings
5Strong Buy
8Buy
5Hold
1Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
17 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 16 neutral. Avg impact: 2.2/10.
NEUTRAL
6-K
1/10
British American Tobacco filed a Form 6-K on June 8, 2026, disclosing a routine insider share purcha
Jun 8, 2026
NEUTRAL
6-K
2/10
CEO Tadeu Marroco and his PCA Luciana Franco Do Amaral purchased 5,000 ordinary shares at £43.06 eac
Jun 5, 2026
NEUTRAL
6-K
1/10
British American Tobacco filed a Form 6-K disclosing routine share purchases by the CEO and other PD
Jun 4, 2026
NEUTRAL
6-K
2/10
This 6-K filing aggregates routine May 2026 corporate disclosures for British American Tobacco, incl
Jun 1, 2026
NEUTRAL
6-K
1/10
British American Tobacco filed a Form 6-K disclosing that Non-Executive Director Serpil Timuray and
May 27, 2026
NEUTRAL
6-K
1/10
British American Tobacco filed a routine 6-K disclosing that CEO Tadeu Marroco and his PCA Luciana F
May 26, 2026
NEUTRAL
6-K
2/10
British American Tobacco's Chief Corporate Officer Kingsley Wheaton sold 781 ordinary shares at an a
May 18, 2026
NEUTRAL
6-K
1/10
British American Tobacco filed a Form 6-K reporting a routine share transfer by the Interim CFO, Jav
May 13, 2026
NEUTRAL
6-K
1/10
British American Tobacco filed a Form 6-K on May 5, 2026, disclosing a routine transfer of 12,283 or
May 5, 2026
NEUTRAL
6-K
2/10
British American Tobacco continues its existing share buyback program, purchasing approximately 260,
May 1, 2026
NEUTRAL
6-K
2/10
British American Tobacco p.l.c. filed a Form 6-K to disclose an initial notification of a transactio
Apr 17, 2026
BULLISH
6-K
7/10
British American Tobacco held its 2026 AGM, where the Chair announced a two-year tenure extension, r
Apr 15, 2026
NEUTRAL
6-K
2/10
British American Tobacco p.l.c. filed a Form 6-K disclosing the transfer of 26,226 ordinary shares f
Apr 10, 2026
NEUTRAL
6-K
5/10
British American Tobacco announced the appointment of Dragos Constantinescu as Chief Financial Offic
Apr 9, 2026
NEUTRAL
6-K
2/10
British American Tobacco disclosed routine insider transactions involving its CEO Tadeu Marroco and
Apr 1, 2026
NEUTRAL
6-K
3/10
British American Tobacco (BTAFF) continued its share buyback program, purchasing 128,140 ordinary sh
Apr 1, 2026
NEUTRAL
6-K
2/10
British American Tobacco filed a Form 6-K to disclose a non-monetary transfer of 26,226 ordinary sha
Mar 30, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 68% buy across 19 analysts — 5 strong buy, 8 buy, 5 hold, 1 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $26.2B | 2.5% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $27.2B | 3.6% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 8 | 5 | 1 | 0 | 68% | |
| May 1, 2026 | 6 | 8 | 5 | 1 | 0 | 70% | |
| Apr 1, 2026 | 6 | 7 | 5 | 2 | 0 | 65% | |
| Mar 1, 2026 | 6 | 7 | 5 | 2 | 0 | 65% | |
| Feb 1, 2026 | 6 | 7 | 5 | 2 | 0 | 65% | |
| Jan 1, 2026 | 6 | 7 | 5 | 2 | 0 | 65% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.